Sponsor LifeSci Holdings has committed to purchase 3,033,333 warrants at 90 cents per warrant for an aggregate purchase price of $2.7 million. The SPAC said it is targeting companies in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors. Read more.
Related Posts
Northern Lights Acquisition Fies for $100M IPO
The SPAC intends to concentrate on companies in the cannabis industry.
AtlasClear and Quantum FinTech Outline Merger in S-4 Filing
Announced in November, the deal also covers the acquisition by AtlasClear of Wilson-Davis & Co., a correspondent clearing broker-dealer.
Sanaby Health Acquisition I Closes $172.5M IPO
Sanaby Health intends to identify opportunities in the healthcare industry, with a focus on digital health, life science tools and services, and innovative therapeutics.
VectoIQ II Files for $300M IPO
The SPAC intends to focus on a business in the industrial technology, transportation and smart mobility industries.